Phase III MIRASOL (GOG 3045/ENGOT-ov55) study: Initial report of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in platinum-resistant, advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression.Kathleen N. Moore, Toon Van Gorp, Jung‐Yun Lee et al.|Journal of Clinical Oncology|2023Cited by 53
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and MetforminTakahiko Sakaue, Karuppaiyah Selvendiran, Kalpana Deepa Priya Dorayappan et al.|Oncogene|2024Cited by 8
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina Haight, Laura Chambers, Quinn Kistenfeger et al.|Gynecologic Oncology|2023Cited by 6
Abstract LB156: Identified the ISG15 mediated extracellular vesicles drives ovarian cancer progression and metastasis: extracellular vesicular ISG15 is a potential biomarker and therapeutic targetKalpana Deepa Priya Dorayappan, Selvendiran Karuppaiyah, Vincent Wagner et al.|Cancer Research|2023Cited by 0